Aurinia Pharmaceuticals Inc. (AUPH) Ownership

$8.38

south_east
-$0.16 (-1.87%)
Day's range
$8.33
Day's range
$8.68

Aurinia Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 8.95 M $80.39 M   -1.26% 6.26%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 8.43 M $75.70 M   16.60% 5.89%
ARMISTICE CAPITAL, LLC 02/14/2025 6.40 M $57.47 M   -21.95% 4.47%
NEA MANAGEMENT COMPANY, LLC 02/14/2025 3.97 M $35.65 M   0.00% 2.78%
STATE STREET CORP 02/14/2025 2.92 M $26.20 M   -0.92% 2.04%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.76 M $15.84 M   -0.11% 1.23%
GOLDMAN SACHS GROUP INC 02/11/2025 1.75 M $15.73 M   -27.24% 1.22%
VANGUARD GROUP INC 02/11/2025 1.73 M $15.53 M   6.93% 1.21%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 1.49 M $13.40 M   10.19% 1.04%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 1.08 M $9.66 M   100.00% 0.75%
JPMORGAN CHASE & CO 02/12/2025 927,298 $8.33 M   84.42% 0.65%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 849,621 $7.63 M   100.00% 0.59%
WOODLINE PARTNERS LP 02/14/2025 849,477 $7.63 M   69.73% 0.59%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 700,900 $6.29 M   44.01% 0.49%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 665,087 $5.97 M   -10.61% 0.46%
CITIGROUP INC 02/12/2025 662,632 $5.95 M   1.29% 0.46%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 596,389 $5.36 M   341.90% 0.42%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 556,454 $5.00 M   22.50% 0.39%
SEGALL BRYANT & HAMILL, LLC 02/11/2025 516,877 $4.64 M   -8.16% 0.36%
CAPTION MANAGEMENT, LLC 02/14/2025 504,300 $4.53 M   305.71% 0.35%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 463,163 $4.16 M   -18.50% 0.32%
TREXQUANT INVESTMENT LP 02/12/2025 442,018 $3.97 M   -24.19% 0.31%
JANE STREET GROUP, LLC 02/14/2025 378,400 $3.40 M   65.38% 0.26%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 363,674 $3.27 M   21.85% 0.25%
BANK OF NEW YORK MELLON CORP 02/04/2025 355,178 $3.19 M   -1.50% 0.25%
NORDEA INVESTMENT MANAGEMENT AB 01/06/2025 338,600 $3.05 M   0.30% 0.24%
PDT PARTNERS, LLC 02/14/2025 301,553 $2.71 M   0.00% 0.21%
STATE OF WISCONSIN INVESTMENT BOARD 02/14/2025 282,012 $2.53 M   -23.78% 0.20%
IFP ADVISORS, INC 02/04/2025 271,132 $2.43 M   30.97% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 263,530 $2.37 M   310.35% 0.18%
BARCLAYS PLC 02/13/2025 243,948 $2.19 M   11.22% 0.17%
SWISS NATIONAL BANK 02/10/2025 239,000 $2.15 M   -9.88% 0.17%
JANE STREET GROUP, LLC 02/14/2025 225,700 $2.03 M   42.13% 0.16%
JANE STREET GROUP, LLC 02/14/2025 222,645 $2.00 M   -52.02% 0.16%
ROYAL BANK OF CANADA 02/14/2025 222,482 $2.00 M   296.53% 0.16%
UBS GROUP AG 02/14/2025 213,273 $1.92 M   41.52% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 212,200 $1.91 M   -63.55% 0.15%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 195,759 $1.76 M   100.00% 0.14%
RHUMBLINE ADVISERS 01/30/2025 193,611 $1.74 M   -0.09% 0.14%
FMR LLC 02/13/2025 179,197 $1.61 M   1,314.01% 0.13%
AMERICAN CENTURY COMPANIES INC 02/11/2025 171,590 $1.54 M   124.23% 0.12%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 168,252 $1.51 M   724.40% 0.12%
INVESCO LTD. 02/13/2025 144,112 $1.29 M   1.00% 0.10%
DEUTSCHE BANK AG\ 02/14/2025 142,869 $1.28 M   54.80% 0.10%
ALLIANCEBERNSTEIN L.P. 02/12/2025 135,500 $1.22 M   0.00% 0.09%
D. E. SHAW & CO., INC. 02/14/2025 133,333 $1.20 M   41.92% 0.09%
LEGAL & GENERAL GROUP PLC 02/13/2025 131,306 $1.18 M   -3.61% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 130,300 $1.17 M   -71.95% 0.09%
SQUAREPOINT OPS LLC 02/14/2025 116,597 $1.05 M   100.00% 0.08%
ALPS ADVISORS INC 02/13/2025 115,772 $1.04 M   6.47% 0.08%

Aurinia Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 245 institutional investors and hedge funds held shares of Aurinia Pharmaceuticals Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 8.95 M

TANG CAPITAL MANAGEMENT LLC: 8.43 M

ARMISTICE CAPITAL, LLC: 6.4 M

NEA Management Company, LLC: 3.97 M

STATE STREET CORP: 2.92 M

GEODE CAPITAL MANAGEMENT, LLC: 1.76 M

40.33% of Aurinia Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 71.59 M shares in the last 24 months. This purchase volume represents approximately $599.90 M in transactions.